It was found that the benefit-risk balance of products containing fenspiride is unfavorable, meaning a risk of use disproportionate to the therapeutic effect and a potential threat to patients’ health or life. Potential effects: serious adverse reactions, life-threatening events, lack of safe therapy.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Eurespal 80 mg film-coated tablets. Check the medicine’s name and dosage form; return any packs in your possession to a pharmacy. If in doubt or if you have been using this medicine, consul...
The Chief Pharmaceutical Inspector withdrew all batches of Eurespal 80 mg film-coated tablets from the market nationwide and granted the decision immediate enforceability after the parallel import aut...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related